[Prognostic factors in breast cancer and their consequences for therapeutic decisions].
Graeff
H
H
Frauenklinik, Technischen Universität München.
Jänicke
F
F
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D002455:Cell Division / Q000502:physiology*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D009376:Neoplasms, Hormone-Dependent / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D011003:Ploidies; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*; D015996:Survival Rate
D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Prognosefaktoren beim Mammacarcinom und ihre Konsequenzen für die Therapieentscheidung.